Acquisitions - Schedule of Intangible Assets Acquired (Details) - USD ($) $ in Thousands |
Mar. 09, 2026 |
Apr. 30, 2026 |
Jan. 31, 2026 |
|---|---|---|---|
| Intangible Asset, Acquired, Indefinite-Lived [Line Items] | |||
| Goodwill | $ 488,161 | $ 439,877 | |
| Rise Healthcare Tech, Inc. (Ostro) | |||
| Intangible Asset, Acquired, Indefinite-Lived [Line Items] | |||
| Fair Value | $ 25,500 | ||
| Goodwill | $ 44,423 | ||
| Rise Healthcare Tech, Inc. (Ostro) | Trade name and trademarks | |||
| Intangible Asset, Acquired, Indefinite-Lived [Line Items] | |||
| Useful life | 3 years | ||
| Fair Value | $ 1,300 | ||
| Rise Healthcare Tech, Inc. (Ostro) | Developed technology | |||
| Intangible Asset, Acquired, Indefinite-Lived [Line Items] | |||
| Useful life | 5 years | ||
| Fair Value | $ 14,500 | ||
| Rise Healthcare Tech, Inc. (Ostro) | Customer relationships | |||
| Intangible Asset, Acquired, Indefinite-Lived [Line Items] | |||
| Useful life | 7 years | ||
| Fair Value | $ 9,700 |
| X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|